Impaired Expression of High Affinity Interleukin 2 Receptor on Activated Lymphocytes from Patients with Systemic Lupus Erythematosus
Overview
Affiliations
Peripheral lymphocytes stimulated with phytohemagglutinin (PHA-blasts) were examined for their responsiveness to exogenous interleukin 2 (IL-2). The proliferative response of PHA-blasts to IL-2 was significantly lower in patients with systemic lupus erythematosus (SLE) than in normal subjects. To clarify the reason for this defect, the expression of IL-2 receptor (IL-2R) on PHA-blasts was investigated using anti-Tac antibody and purified IL-2. Cytofluorometric analysis showed no statistical differences in the Tac positivity of PHA-blasts among normal subjects and patients with active and inactive SLE. Scatchard analysis using 125I-labeled anti-Tac monoclonal antibody revealed that the number of Tac epitopes on PHA-blasts was also not different among them. Next, the affinity of IL-2R expressed on PHA-blasts was determined by Scatchard analysis using radiolabeled IL-2 as a ligand. The number of high affinity IL-2R on the PHA-blasts was significantly decreased in patients with active and inactive SLE, as compared with normal subjects. The responsiveness of PHA-blasts to exogenous IL-2 was well correlated to the number of high affinity IL-2R, but not to the number of Tac epitopes or total IL-2R. Inasmuch as high affinity components of IL-2R are functionally active, the defective expression of high affinity IL-2R may be responsible for the T cell dysfunctions in SLE.
Hedrich C, Rauen T, Tsokos G J Biol Chem. 2011; 286(50):43429-36.
PMID: 21976679 PMC: 3234875. DOI: 10.1074/jbc.M111.299339.
The IL-2 defect in systemic lupus erythematosus disease has an expansive effect on host immunity.
Lieberman L, Tsokos G J Biomed Biotechnol. 2010; 2010:740619.
PMID: 20625413 PMC: 2896881. DOI: 10.1155/2010/740619.
Cytokines in systemic lupus erythematosus.
Lourenco E, La Cava A Curr Mol Med. 2009; 9(3):242-54.
PMID: 19355907 PMC: 3589140. DOI: 10.2174/156652409787847263.
Martorell J, Font J, Rojo I, Vilella R, Ingelmo M, Vives J Clin Exp Immunol. 1989; 78(2):172-6.
PMID: 12412744 PMC: 1534680.
Circulating TCR gammadelta cells in the patients with systemic lupus erythematosus.
Robak E, Blonski J, Bartkowiak J, Niewiadomska H, Sysa-Jedrzejowska A, Robak T Mediators Inflamm. 2000; 8(6):305-12.
PMID: 10815619 PMC: 1781811. DOI: 10.1080/09629359990315.